National Pediatric Cancer Foundation Inc
NATIONAL PEDIATRIC CANCER, based in Tampa, Florida, is a public charity that funds pediatric cancer research and clinical trials. Its website describes the National Pediatric Cancer Foundation (NPCF) as a nonprofit dedicated to developing less toxic, more effective treatments for childhood cancer, improving survival, and ultimately eliminating childhood cancer.
National Pediatric Cancer Foundation Inc at a glance
In short: National Pediatric Cancer Foundation Inc gave $3.4M across 15 grants in 2025 (avg $229K), top state Michigan. 7% of 2025 grantees were new. Source: 2025 IRS Form 990.
- Annual giving (2025)
- $3,429,303
- +22.2% vs 2024
- Grants made (2025)
- 15
- +7.1% vs 2024
- Average grant
- $228,620
- +14.0% vs 2024
- Median grant
- $95,071
- Total assets
- $6,202,847
- -11.8% vs 2024
- New grantees (estimate)
- 7% first-time grantees (1 of 15, 2025; small sample)
- Primary geography
- Michigan (29% of itemized 2025 grant dollars)
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated September 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to National Pediatric Cancer Foundation Inc
- Review Cycle
- The RFA’s 2025 cycle is past. It listed July 1, 2025, for letters of intent and November 1, 2025, for full proposals. The RFA webpage later stated that winner announcements were delayed until February 6, 2026.
- Deadline
- The RFA’s 2025 cycle is past.
- Contact
Mailing address: 5550 West Executive Drive Suite 20, Tampa, FL 33609
Phone: (813) 269-0955
Website: https://nationalpcf.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who National Pediatric Cancer Foundation Inc funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was The Research Institute at Nationwide Children's Hospital ($992K). Together the top 10 received $3.2M.
Grant Size Distribution
76 grants across all recorded years
The most common grant size was under $50K: 25 grants of 76 (33%).
Geographic Focus
Where this funder awards grants
NPCF describes the Sunshine Research Consortium as a nationwide collaboration. In 2025, grant dollars were distributed among recipients in multiple states; the largest reported shares went to Michigan (29%), Florida (26%), and New York (21%), followed by California and Ohio (6% each).
Grant Distribution by State
Share of 2025 grant dollars across all 15 itemized grants.
States
Cities
Is National Pediatric Cancer Foundation Inc open to new grantees?
7%
first-time grantees, 2025
In 2025, 1 of 15 grantees (7%) were first-time recipients. With only 15 grantees, that is a small sample: one grantee more or less moves the share by about 7 points. First grants averaged $44K; repeat grants $242K. How we count
Medians: $44K first-time, $99K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2021–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2021 to 2025, annual grant giving ranged from $2.6M (2021) to $3.4M (2025). In 2025 it made 15 grants totaling $3.4M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| The Research Institute at Nationwide Children's Hospital Detroit, MI | In support of clinical trials conducted under the sunshine project. | $992,092 |
| Albert Einstein College of Medicine Bronx, NY | For 43 challenge project - engineered destabilized au rich elements of c-myc 3utr as therapeutics for c-myc driven pediatric cancers and one caron meta in ewing sarcoma trial | $713,110 |
| H Lee Moffit Cancer Center and Research Institute Tampa, FL | In support of clinical trials conducted under the sunshine project. | $657,764 |
| The Regents of the University of California Los Angeles, CA | For 43 challenge project - treating leptomeningeal spread of pediatric medulloblastoma with quantum radiobiology | $200,000 |
| Cleveland Clinic Foundation Cleveland, OH | In support of clinical trials conducted under the sunshine project. | $192,451 |
| H Lee Moffit Cancer Center and Research Institute Foundation Inc Tampa, FL | In support of clinical trials conducted under the sunshine project. | $110,000 |
| The University of North Carlina at Chapel Hill Chapel Hill, NC | In support of clinical trials conducted under the sunshine project. | $102,500 |
| Children's Research Institute Silver Spring, MD | In suport of inkt trial conducted under the sunshine project | $95,071 |
| University of Colorado Aurora, CO | In support of clinical trials conducted under the sunshine project. | $91,654 |
| University of Florida Gainesville, FL | In Support of Clinical Trial Advancing Inkt Study | $64,417 |
Ready to take the next step with National Pediatric Cancer Foundation Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $6,202,847 | $4,449,969 | $5,723,050 | $3,429,303 | 15 | $87,081 |
| 2024 | $7,031,609 | $5,010,088 | $5,075,041 | $2,806,572 | 14 | $161,711 |
| 2023 | $6,837,500 | $4,849,523 | $4,951,075 | $2,891,189 | 15 | $128,799 |
| 2022 | $5,857,840 | $4,349,128 | $4,273,754 | $2,657,545 | 17 | $99,773 |
| 2021 | $6,651,091 | $4,333,926 | $4,055,107 | $2,628,112 | 15 | $112,311 |
Research compiled by Grantable AI from public sources. Last updated September 2026.
Mission & Focus Areas
NPCF states that its mission is to fund research to eliminate childhood cancer, with a focus on finding less toxic, more targeted therapies through partnerships with leading hospitals. Its 2024 filing describes the Sunshine Project as a collaboration of 40 hospitals conducting basic science, translational research, and clinical trials. Listed research initiatives include trials and studies involving sarcomas, brain cancers, and solid tumors.
The 2025 grants show support for clinical trials under the Sunshine Project, as well as projects on pediatric cancers including rhabdomyosarcoma, Ewing sarcoma, and medulloblastoma. Grantees include hospitals and academic and research institutions. For example, Connecticut Children’s Medical Center describes its own mission as improving children’s physical and emotional health through family-centered care, research, education, and advocacy.
Grantmaking
In filing year 2025, NPCF reported 15 grants totaling $3,429,303. Grant amounts ranged from $37,118 to $992,092, with a median grant of $95,071.
Among the largest reported grants were $992,092 to The Research Institute at Nationwide Children’s Hospital for Sunshine Project clinical trials; $713,110 to Albert Einstein College of Medicine for a project on engineered destabilized AU-rich elements of C-MYC 3′UTR and a trial in Ewing sarcoma; and $657,764 to H Lee Moffitt Cancer Center and Research Institute for Sunshine Project clinical trials. Other notable grants included $200,000 to The Regents of the University of California for research on leptomeningeal spread of pediatric medulloblastoma, and $192,451 to Cleveland Clinic Foundation for Sunshine Project clinical trials.
The foundation’s 2025 request for applications on treatment resistance in metastatic fusion-positive rhabdomyosarcoma offered up to $1,000,000 for a period of up to five years. Proposals were to address mechanisms and biological insights into therapy resistance; basic and developmental biology were permitted, and translational science and the use of models and human samples were encouraged. Clinical trials were not supported under this RFA. Applicants were required to have an MD, PhD, or equivalent and a faculty or equivalent appointment; applicant institutions had to be U.S.-based, and funding was limited to nonprofit institutions or organizations.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists Albert Silva as chairman of the board; Michael Levin as past chair; Richard Huff and Alex Sullivan as vice chairmen; Jeremy Persinger as treasurer; John Fitzpatrick as secretary; and Michael Weigner as assistant secretary. It also lists Melissa Dunkel as co-founder at large and Jim Bassil and BB Abbott as directors.
National Pediatric Cancer Foundation Inc is led by David Frazer, CEO on every filing since 2021; 4 of 26 officers listed in 2025 are compensated.
Officers on the 2025 filing
David Frazer
CEO
On filings since 2021
40 hrs/week
$197K (2021) → $210K (2025)
Albert Silva
Chairman of the Board
Vice Chairman → Chairman of the Board, 2025
On filings since 2024
2 hrs/week
No compensation reported
Angela North
Director
On filings since 2021
1 hr/week
No compensation reported
Bb Abbott
Director
On filings since 2021
1 hr/week
No compensation reported
Carrie Charles
Director
On filings since 2021
1 hr/week
No compensation reported
Chris Carrere
Director at Large
At Large → Director, 2024
Director → Director at Large, 2025
On filings since 2021
1 hr/week
No compensation reported
Dawn Siler-Nixon
Director
On filings since 2021
1 hr/week
No compensation reported
Jay Langford
Director
On filings since 2021
1 hr/week
No compensation reported
Jeff Maxwell
Director at Large
At Large → At Large Director, 2024
At Large Director → Director at Large, 2025
On filings since 2021
1 hr/week
No compensation reported
Jim Bassil
Director
Secretary → Director, 2025
On filings since 2021
1 hr/week
No compensation reported
Joseph Lamphier
Director
Director → Director - Emeritus, 2024
Director - Emeritus → Director, 2025
On filings since 2021
1 hr/week
No compensation reported
David Boyington
Director
On filings since 2023
1 hr/week
No compensation reported
Marco Schnabl
Director at Large
Director → Director at Large, 2025
On filings since 2023
1 hr/week
No compensation reported
Mark McHugh
Director at Large
Director → Director at Large, 2025
On filings since 2023
1 hr/week
No compensation reported
Ashlie Teeling
Director
New on the 2025 filing
1 hr/week
No compensation reported
Dawn Zachman
COO
On filings since 2024
40 hrs/week
$113K (2024) → $120K (2025)
Robert Martin
CFO
On filings since 2024
40 hrs/week
$145K (2024) → $132K (2025)
Jennifer Finnemore
CFO Start October
New on the 2025 filing
40 hrs/week
$30K (2025)
Alex Sullivan
Vice Chairman
Past Chairman → Director, 2024
Director → Vice Chairman, 2025
On filings since 2021
2 hrs/week
No compensation reported
Chad Harrod
Emeritus
Vice Chairman → Emeritus, 2025
On filings since 2021
1 hr/week
No compensation reported
Jeremy Persinger
Treasurer
Director → Treasurer, 2023
On filings since 2021
2 hrs/week
No compensation reported
John Fitzpatrick
Secretary
Director → Secretary, 2025
On filings since 2021
2 hrs/week
No compensation reported
Melissa Dunkel
Co-Founder at Large
Co-Founder at Large Emeritus → At Large Director - Emeritus, 2024
At Large Director - Emeritus → Co-Founder at Large, 2025
On filings since 2021
1 hr/week
No compensation reported
Michael Levin
Past Chair
Treasurer → Chairman of the Board, 2023
Chairman of the Board → Past Chair, 2025
On filings since 2021
2 hrs/week
No compensation reported
Richard Huff
Vice Chairman
At Large → Director, 2024
Director → Vice Chairman, 2025
On filings since 2021
2 hrs/week
No compensation reported
Michael Weigner
Assistant Secretary
New on the 2025 filing
2 hrs/week
No compensation reported
Former officers (7)
- Former: Dan Doyle Jr. (2021–2024) — Director
- Former: Frank Capitano (2021–2024) — At Large Director
- Former: Mike Weigner (2021–2024) — Director
- Former: Philip Minardi (2021–2024) — Director
- Former: Al Silva (2021–2023) — Vice Chairman
- Former: Joe Taggart (2021–2023) — Director
- Former: Thomas Grossjung (2021–2023) — Director
Data from IRS Form 990 filings, 2021–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $210K, to David Frazer (CEO). 4 officers or directors reported compensation on that filing.
Frequently asked questions about National Pediatric Cancer Foundation Inc
How much does National Pediatric Cancer Foundation Inc give each year?
National Pediatric Cancer Foundation Inc gave $3.4M across 15 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $2.8M across 14 grants.
What is National Pediatric Cancer Foundation Inc's typical grant size?
National Pediatric Cancer Foundation Inc's median grant in 2025 was $95,071, and its average grant was $228,620, across 15 grants on its 2025 IRS Form 990. Organizations receiving their first grant from National Pediatric Cancer Foundation Inc that year got $44K on average.
Where does National Pediatric Cancer Foundation Inc give grants?
National Pediatric Cancer Foundation Inc's top state is Michigan, with 29% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were Florida (26%) and New York (21%). The most frequent recipient cities were Tampa, FL (2 grants).
Does National Pediatric Cancer Foundation Inc give general operating support?
Not in 2025: none of the 15 grants with a stated purpose on National Pediatric Cancer Foundation Inc's 2025 IRS Form 990 were described as general or operating support.
Who are National Pediatric Cancer Foundation Inc's largest grantees?
National Pediatric Cancer Foundation Inc's largest 2025 grantees include The Research Institute at Nationwide Children's Hospital ($992,092), Albert Einstein College of Medicine ($713,110) and H Lee Moffit Cancer Center and Research Institute ($657,764), according to its 2025 IRS Form 990. Together they received 69% of its itemized 2025 grant dollars.
How large is National Pediatric Cancer Foundation Inc?
National Pediatric Cancer Foundation Inc reported $6.2M in total assets on its 2025 IRS Form 990. Its revenue that year was $4.4M.
What does National Pediatric Cancer Foundation Inc fund?
NPCF states that its mission is to fund research to eliminate childhood cancer, with a focus on finding less toxic, more targeted therapies through partnerships with leading hospitals. See mission & focus areas ↑
How do I apply for a grant from National Pediatric Cancer Foundation Inc?
National Pediatric Cancer Foundation Inc has no public application process in the sources Grantable reviewed. Check nationalpcf.org for current guidelines, or contact the foundation directly before submitting a request.
What is National Pediatric Cancer Foundation Inc's EIN?
National Pediatric Cancer Foundation Inc's EIN (Employer Identification Number) is 59-3097333. IRS Form 990 filing data is available on this page for 2021–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2021 (received by the IRS October 6, 2021)
- Updated Form 990 for fiscal year 2022 (received by the IRS February 28, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS October 10, 2023)
- Updated Form 990 for fiscal year 2024 (received by the IRS October 22, 2024)
- Updated Form 990 for fiscal year 2025 (received by the IRS October 17, 2025)
- IRS filings on file for fiscal years 2021–2025
Live grants for the work National Pediatric Cancer Foundation Inc funds
Health Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in National Pediatric Cancer Foundation Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Conquer Cancer Foundation of the American Society of Clinical Oncology
Alexandria, VA
Conquer Cancer funds cancer research, professional education, and quality-care initiatives, with awards to universities, hospitals, and cancer centers in the U.S. and through international programs. Its 2024 grants ranged from $50,000 to $7.68 million, with a median of $100,000; the profile does not state whether it accepts unsolicited requests.
Assets
$120.7M
Grants
39
Total Given
$17.4M
Alexs Lemonade Stand Foundation
Wynnewood, PA
Alex’s Lemonade Stand Foundation primarily funds pediatric cancer research, including early-stage science and clinical trials, with additional programs supporting affected families and raising awareness. Its 2025 grants ranged from $6,000 to $2.3 million, with a median of about $162,000, and supported institutions in the United States, Canada, and Europe; the profile does not state whether it accepts unsolicited requests.
Assets
$40.6M
Grants
58
Total Given
$19.1M
Blood Cancer United Inc
Washington, DC
Blood Cancer United funds blood cancer research, including basic, translational, and clinical studies, along with patient and family support, quality-of-life work, and advocacy. Its 2025 grants ranged from $37,500 to $5,197,687, with a median of $370,000; funding supports work in the U.S. and internationally. The profile does not state whether it accepts unsolicited requests.
Assets
$532.2M
Grants
67
Total Given
$47.7M
American Thrombosis and Hemostasis Network Inc
Hickory, NC
The American Thrombosis and Hemostasis Network funds data management and research projects that improve care for people with bleeding and clotting disorders, including work by treatment centers, hospitals, universities, and community organizations. Its 2024 grants ranged from $5,324 to $566,663, with a median of $14,400, and went to recipients in multiple U.S. states. The profile does not state whether it accepts unsolicited requests.
Assets
$5.2M
Grants
71
Total Given
$4.8M
Hyundai Hope on Wheels
Fountain Valley, CA
Hyundai Hope on Wheels funds hospital-based pediatric cancer research and treatment programs at eligible Children’s Oncology Group member institutions across the United States. Its 2025 awards ranged from $100,000 to $400,000 for named grant programs; in 2024, grants had a median of $125,000. Applications are described through specific grant programs, but the profile does not state whether it accepts unsolicited requests.
Assets
$21.6M
Grants
108
Total Given
$26.1M
The Children's Hospital of Philadelphia
Philadelphia, PA
CHOP primarily funds pediatric research at universities, hospitals, and research organizations, and also supports employee-led health projects in communities served by CHOP and its Care Network in Pennsylvania and New Jersey. In 2025, it awarded 138 grants totaling about $50.3 million; the median grant was about $115,000, with awards ranging from about $5,800 to $14 million. The profile does not state whether CHOP accepts unsolicited requests.
Assets
$9.1B
Grants
138
Total Given
$50.3M
More similar funders
More Funders in Florida
Cite this profile
Grantable. (2026). National Pediatric Cancer Foundation Inc funder profile. GrantGraph. Retrieved October 20, 2026, from https://grantable.co/funders/national-pediatric-cancer-foundation-inc-morg_5564b5621eff430cb0cdd72ffb39ec6d
BibTeX
@misc{grantable_593097333_2026,
author = {{Grantable}},
title = {{National Pediatric Cancer Foundation Inc funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/national-pediatric-cancer-foundation-inc-morg_5564b5621eff430cb0cdd72ffb39ec6d},
note = {Accessed 2026-10-20. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from National Pediatric Cancer Foundation Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
National Pediatric Cancer Foundation Inc down — hundreds of funders to go?